News

WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
WHO recommends Gilead's twice-yearly injection for HIV prevention
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
HIV prevention gets an AI upgrade
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
BioWorld41m
IAS 2025: All eyes still on the HIV reservoir
While people living with HIV can lead virtually normal lives thanks to antiretroviral therapy (ART), HIV persists in a latent ...
Lisa Jarvis: When an HIV scientific breakthrough isn’t enough
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
The American Journal of Managed Care1h
Most Patients With HIV Opted for Injectable ART, PrEP in Phase 3 Trial
New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.
Loss of $4M grant threatens HIV prevention efforts in Tennessee
This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across ...
STAT18h
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
New Study Shows How Providers Can Use Apretude To Prevent And Treat HIV In Black Women
A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...
ViiV expands licence to allow generic HIV treatment production for low-income countries
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
The Observer3h
Standard HIV treatment may cause bone, kidney harm in older persons – research
Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...